Heartflow CT-Guided PCI Planning Meets P4 Trial Primary Endpoint
Heartflow said its CT-guided PCI planning met the primary endpoint in the P4 trial.
Related stories
Tempus AI Q3 Revenue Slightly Beats Estimates; Raises Guidance
Tempus AI reported Q3 revenue slightly above estimates and raised guidance.
M impact | EQUITY | Nov 02, 2026, 12:10 PM UTC
Tower Semiconductor Q3 Net Profit More Than Doubles to $119.89 Million
M impact | EQUITY | Nov 02, 2026, 12:09 PM UTC
Tempus AI cuts Q3 2026 net loss 81%
Tempus AI reported that its net loss fell 81% in the third quarter of 2026.
M impact | EQUITY | Nov 02, 2026, 12:09 PM UTC
NAPCO Q1 Revenue Misses Estimates on Lower Distributor Purchases
NAPCO's first-quarter revenue missed estimates as distributor purchases declined.
M impact | EQUITY | Nov 02, 2026, 12:09 PM UTC
Marvell Narrows Fiscal Q3 2027 Revenue Guidance Range to ±2%, Maintains Midpoint
M impact | EQUITY | Nov 02, 2026, 12:08 PM UTC
Marriott worldwide RevPAR increased 6.5%
M impact | EQUITY | Nov 02, 2026, 12:08 PM UTC